BioRun
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioRun - overview
Established
2011
Location
Wuhan, Hubei, China
Primary Industry
Biotechnology
About
Established in 2011 and based in Wuhan, China, BioRun operates as a biotechnology company dedicated to providing services such as gene cloning and protein expression vector construction. It has sub-branch offices in Sanya and Huanggang. The company acquired PCT US patent authorization and has applied for more than ten patents. The founder and CEO of the company, Yang Li graduated from Wuhan University.
In 2022, the company obtained the title of High-tech Enterprise. In January 2024, BioRun closed series A funding. The company mainly provides platforms for the research and application of functional genes in animals and plants. The platforms include genetic transformation platform, detection platform, protein platform, and synthetic biology platform.
The company's platforms can provide services such as gene cloning, gene synthesis, DNA cloning and construction, and crop transgenic research. BioRun also provides an e-commercial platform named BioRun Strict Selection, which provides products such as molecular biology agents, culture media, and biological reagents. The service targets include scientific research institutes and seed companies. The company will build multi-omics platform.
Current Investors
Addor Capital, Zhongli Capital, Baiying Bio-industry Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Farm Support Services
Website
www.biorun.com
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only
BioRun - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.